|
SRI expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.716000E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.721100E-03 |
| Normal-vs-Stage2 |
2.552000E-01 |
| Normal-vs-Stage3 |
2.836000E-04 |
| Normal-vs-Stage4 |
2.665600E-02 |
| Stage1-vs-Stage2 |
3.952600E-01 |
| Stage1-vs-Stage3 |
6.380400E-02 |
| Stage1-vs-Stage4 |
9.191400E-01 |
| Stage2-vs-Stage3 |
5.573600E-02 |
| Stage2-vs-Stage4 |
4.223000E-01 |
| Stage3-vs-Stage4 |
1.842580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.800900E-03 |
| Normal-vs-AfricanAmerican |
1.616080E-03 |
| Normal-vs-Asian |
5.663400E-01 |
| Caucasian-vs-AfricanAmerican |
2.898200E-01 |
| Caucasian-vs-Asian |
6.366200E-01 |
| AfricanAmerican-vs-Asian |
3.143600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.693800E-02 |
| Normal-vs-Female |
2.05119999999726E-05 |
| Male-vs-Female |
1.586060E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.364010E-01 |
| Normal-vs-Age(41-60Yrs) |
2.817500E-04 |
| Normal-vs-Age(61-80Yrs) |
2.809700E-02 |
| Normal-vs-Age(81-100Yrs) |
5.800000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.425400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.267000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.101200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.324430E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.797000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.531600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.300700E-03 |
| Normal-vs-Grade 2 |
3.648400E-02 |
| Normal-vs-Grade 3 |
8.07409999999953E-05 |
| Normal-vs-Grade 4 |
9.976500E-04 |
| Grade 1-vs-Grade 2 |
1.570430E-01 |
| Grade 1-vs-Grade 3 |
7.826800E-01 |
| Grade 1-vs-Grade 4 |
9.781000E-01 |
| Grade 2-vs-Grade 3 |
5.595700E-02 |
| Grade 2-vs-Grade 4 |
8.363700E-02 |
| Grade 3-vs-Grade 4 |
6.047200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.213300E-04 |
| Normal-vs-ccB subtype |
4.514100E-02 |
| ccA subtype-vs-ccB subtype |
1.530810E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.238040E-02 |
| Normal-vs-N1 |
2.500400E-01 |
| N0-vs-N1 |
9.397000E-01 |
|
|
